Concepedia

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer

Francesco Cantiello, Giorgio Ivan Russo, Mihai Dorin Vartolomei, Abdal Rahman Abu Farhan, Daniela Terracciano, Gennaro Musi, Giuseppe Lucarelli, Savino M. Di Stasi, Rodolfo Hurle, Vincenzo Serretta,

European Urology Oncology · 2018 · 89 citations · 10 references

DOIFull text

Open access

Concepts

References

10

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Marko Babjuk, Andreas Böhle, Maximilian Burger et al. · European Urology · 2016 · 2.3K citations

, , +16

Pretreatment Neutrophil-to-Lymphocyte Ratio Is Associated with Advanced Pathologic Tumor Stage and Increased Cancer-specific Mortality Among Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy

Boyd R. Viers, Stephen A. Boorjian, Igor Frank et al. · European Urology · 2014 · 181 citations

, , +16

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy

Arnoud J. Templeton, Jennifer J. Knox, Xun Lin et al. · European Urology · 2016 · 151 citations · Full text

, , +14

Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and platelet count as predictors of long-term outcome after R0 resection for colorectal cancer

Corrado Pedrazzani, G. Mantovani, Eduardo Fernandes et al. · Scientific Reports · 2017 · 113 citations · Full text

, , +15

Discrepancy Between European Association of Urology Guidelines and Daily Practice in the Management of Non–muscle-invasive Bladder Cancer: Results of a European Survey

Kees Hendricksen, Atiqullah Aziz, Perrine Bes et al. · European Urology Focus · 2017 · 77 citations · Full text

, , +11